$AGIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AGIOS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AGIOS PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 51.51 | 1,777 | 91,533 | 3,555 | |
Jun 23 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 61.61 | 1,777 | 109,481 | 0 | 1.8 K to 0 (-100.00 %) |
Jun 23 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 51.51 | 1,777 | 91,533 | 1,777 | 0 to 1.8 K |
Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | M | 0.00 | 1,686 | 0 | 0 | |
Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | M | 0.00 | 1,686 | 0 | 28,443 | 26.8 K to 28.4 K (+6.30 %) |
Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Gift | G | 0.00 | 3,415 | 0 | 26,757 | 30.2 K to 26.8 K (-11.32 %) |
Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 1,686 | 0 | 0 | |
Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 1,686 | 0 | 114,277 | 112.6 K to 114.3 K (+1.50 %) |
May 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 56.76 | 8,888 | 504,483 | 8,888 | |
May 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 56.76 | 8,888 | 504,483 | 8,888 | |
May 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 0.00 | 1,585 | 0 | 1,585 | |
May 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 0.00 | 1,585 | 0 | 1,585 | |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 39.76 | 1,888 | 75,067 | 43,332 | |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 12,513 | 439,957 | 0 | |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 3,210 | 112,864 | 12,513 | |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 55.11 | 14,401 | 793,582 | 15,487 | 29.9 K to 15.5 K (-48.18 %) |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 39.76 | 1,888 | 75,067 | 29,888 | 28 K to 29.9 K (+6.74 %) |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 12,513 | 439,957 | 28,000 | 15.5 K to 28 K (+80.80 %) |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 55.16 | 3,210 | 177,055 | 15,487 | 18.7 K to 15.5 K (-17.17 %) |
Apr 21 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 3,210 | 112,864 | 18,697 | 15.5 K to 18.7 K (+20.73 %) |
Apr 20 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 55.89 | 1,118 | 62,485 | 0 | 1.1 K to 0 (-100.00 %) |
Apr 16 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 54.00 | 991 | 53,514 | 1,118 | 2.1 K to 1.1 K (-46.99 %) |
Apr 15 2021 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Option Exercise | M | 0.00 | 3,437 | 0 | 6,874 | |
Apr 15 2021 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Payment of Exercise | F | 44.09 | 1,191 | 52,506 | 7,093 | 8.3 K to 7.1 K (-14.38 %) |
Apr 15 2021 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Buy | M | 0.00 | 3,437 | 0 | 8,284 | 4.8 K to 8.3 K (+70.91 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 2,774 | 0 | 2,775 | |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 0.00 | 821 | 0 | 112,591 | 113.4 K to 112.6 K (-0.72 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 2,774 | 0 | 113,412 | 110.6 K to 113.4 K (+2.51 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 692 | 0 | 691 | |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 0.00 | 199 | 0 | 1,795 | 2 K to 1.8 K (-9.98 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 692 | 0 | 1,994 | 1.3 K to 2 K (+53.15 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,334 | 0 | 3,333 | |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 986 | 0 | 15,410 | 16.4 K to 15.4 K (-6.01 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 3,334 | 0 | 16,396 | 13.1 K to 16.4 K (+25.52 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 0 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 4,000 | 0 | 8,000 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 0.00 | 2,069 | 0 | 13,062 | 15.1 K to 13.1 K (-13.67 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 15,131 | 12.4 K to 15.1 K (+22.21 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 4,000 | 0 | 12,381 | 8.4 K to 12.4 K (+47.73 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,333 | 0 | 22,667 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 3,398 | 0 | 58,363 | 61.8 K to 58.4 K (-5.50 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 11,333 | 0 | 61,761 | 50.4 K to 61.8 K (+22.47 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 790 | 0 | 0 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 0.00 | 561 | 0 | 1,302 | 1.9 K to 1.3 K (-30.11 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 790 | 0 | 1,863 | 1.1 K to 1.9 K (+73.63 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 889 | 0 | 1,073 | 184 to 1.1 K (+483.15 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 8,125 | 0 | 0 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 0.00 | 2,540 | 0 | 110,638 | 113.2 K to 110.6 K (-2.24 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 8,125 | 0 | 113,178 | 105.1 K to 113.2 K (+7.73 %) |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Option Exercise | A | 56.68 | 44,000 | 2,493,920 | 44,000 | |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 56.68 | 44,000 | 2,493,920 | 44,000 | |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Biller Jonathan | Chief Financial Off ... | Option Exercise | A | 56.68 | 44,000 | 2,493,920 | 44,000 | |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Biller Jonathan | Chief Financial Off ... | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 56.68 | 2,961 | 167,829 | 2,961 | |
Feb 12 2021 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 5,922 | 0 | 5,922 | |
Oct 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Sep 04 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 39.93 | 250 | 9,983 | 184 | 434 to 184 (-57.60 %) |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Buy | M | 0.00 | 1,878 | 0 | 3,849 | 2 K to 3.8 K (+95.28 %) |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Buy | M | 0.00 | 1,878 | 0 | 3,278 | 1.4 K to 3.3 K (+134.14 %) |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 0.00 | 1,878 | 0 | 5,478 | 3.6 K to 5.5 K (+52.17 %) |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Buy | M | 0.00 | 1,878 | 0 | 3,278 | 1.4 K to 3.3 K (+134.14 %) |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Buy | M | 0.00 | 1,878 | 0 | 30,172 | 28.3 K to 30.2 K (+6.64 %) |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Buy | M | 0.00 | 1,878 | 0 | 3,278 | 1.4 K to 3.3 K (+134.14 %) |
May 21 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 3,583 | 125,978 | 15,723 | |
May 21 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.01 | 3,583 | 179,200 | 8,306 | 11.9 K to 8.3 K (-30.14 %) |
May 21 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 3,583 | 125,978 | 11,889 | 8.3 K to 11.9 K (+43.14 %) |
Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,893 | 0 | 11,785 | |
Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 45.91 | 1,927 | 88,469 | 24,272 | 26.2 K to 24.3 K (-7.36 %) |
Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 5,893 | 0 | 26,199 | 20.3 K to 26.2 K (+29.02 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Biller Jonathan | Chief Legal Officer | Option Exercise | M | 0.00 | 8,523 | 0 | 17,045 | |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Biller Jonathan | Chief Legal Officer | Payment of Exercise | F | 40.64 | 2,529 | 102,779 | 5,994 | 8.5 K to 6 K (-29.67 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Biller Jonathan | Chief Legal Officer | Buy | M | 0.00 | 8,523 | 0 | 8,523 | 0 to 8.5 K |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,387 | 0 | 10,775 | |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 40.64 | 1,599 | 64,983 | 20,306 | 21.9 K to 20.3 K (-7.30 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 5,387 | 0 | 21,905 | 16.5 K to 21.9 K (+32.61 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,379 | 0 | 24,759 | |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Payment of Exercise | F | 40.64 | 3,673 | 149,271 | 50,428 | 54.1 K to 50.4 K (-6.79 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 12,379 | 0 | 54,101 | 41.7 K to 54.1 K (+29.67 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Option Exercise | M | 0.00 | 6,874 | 0 | 13,748 | |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Payment of Exercise | F | 40.64 | 2,027 | 82,377 | 4,847 | 6.9 K to 4.8 K (-29.49 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Car Bruce | Chief Scientific Of ... | Buy | M | 0.00 | 6,874 | 0 | 6,874 | 0 to 6.9 K |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 5,280 | 0 | 10,561 | |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 40.64 | 2,368 | 96,236 | 8,230 | 10.6 K to 8.2 K (-22.34 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 5,280 | 0 | 10,598 | 5.3 K to 10.6 K (+99.29 %) |
Mar 04 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 47.30 | 345 | 16,319 | 184 | 529 to 184 (-65.22 %) |
Feb 28 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 47.12 | 472 | 22,241 | 184 | 656 to 184 (-71.95 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,333 | 0 | 6,667 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 48.66 | 1,056 | 51,385 | 16,518 | 17.6 K to 16.5 K (-6.01 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 3,333 | 0 | 17,574 | 14.2 K to 17.6 K (+23.40 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,333 | 0 | 6,667 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 48.66 | 1,596 | 77,661 | 5,318 | 6.9 K to 5.3 K (-23.08 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 3,333 | 0 | 6,914 | 3.6 K to 6.9 K (+93.07 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 2,775 | 0 | 5,549 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 48.66 | 880 | 42,821 | 105,053 | 105.9 K to 105.1 K (-0.83 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 2,775 | 0 | 105,933 | 103.2 K to 105.9 K (+2.69 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 691 | 0 | 1,383 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 48.66 | 219 | 10,657 | 656 | 875 to 656 (-25.03 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 691 | 0 | 875 | 184 to 875 (+375.54 %) |
Feb 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Sell | S | 53.37 | 2,427 | 129,529 | 184 | 2.6 K to 184 (-92.95 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | M | 0.00 | 790 | 0 | 790 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 51.51 | 5,332 | 274,651 | 5,332 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 4,800 | 0 | 4,800 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Option Exercise | A | 0.00 | 2,666 | 0 | 2,666 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Payment of Exercise | F | 52.01 | 1,163 | 60,488 | 2,611 | 3.8 K to 2.6 K (-30.82 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 2,800 | 0 | 3,774 | 974 to 3.8 K (+287.47 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Alenson Carman | Principal Accountin ... | Buy | M | 0.00 | 790 | 0 | 974 | 184 to 974 (+429.35 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 2,750 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 51.51 | 45,000 | 2,317,950 | 45,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 52.01 | 819 | 42,596 | 3,581 | 4.4 K to 3.6 K (-18.61 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 4,400 | 1.7 K to 4.4 K (+166.67 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 34,000 | 0 | 34,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 51.51 | 137,000 | 7,056,870 | 137,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,750 | 0 | 2,750 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 51.51 | 45,000 | 2,317,950 | 45,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 52.01 | 886 | 46,081 | 14,241 | 15.1 K to 14.2 K (-5.86 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 2,750 | 0 | 15,127 | 12.4 K to 15.1 K (+22.22 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 8,125 | 0 | 8,125 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 52.01 | 2,534 | 131,793 | 103,158 | 105.7 K to 103.2 K (-2.40 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 8,125 | 0 | 105,692 | 97.6 K to 105.7 K (+8.33 %) |
Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 621 | 21,834 | 26,406 | |
Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.02 | 621 | 31,063 | 1,650 | 2.3 K to 1.7 K (-27.34 %) |
Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 621 | 21,834 | 2,271 | 1.7 K to 2.3 K (+37.64 %) |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 35,447 | 1,246,317 | 27,027 | |
Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 8,526 | 299,774 | 62,474 |